Skip to content

CAPITOLIUM

Active Public limited companyfounded 2002active for 24 yearsTongerenstraat 25, 1040 EtterbeekKBO/BCE: BE 0477.642.648 subsidiary of
Part of the group 14 companies

Lifetime

24 annual accounts with figures on one time axis
peak of €165,597 in 2013
€30,212▼ 5.6%
lowest -€53,707 in 2005
€14,291▼ 8.7%
peak of €394,084 in 2022
€349,657▼ 9.3%
€438,036▲ 4.4%
peak of 2.2 FTE in 2014
-not published
Board4 names since 2014
4 directors and 3 others
Owners2 names in the annual accounts
  
Documentsfilings and deeds
31-07-2026on the last day
2025micro format
Company renamed from GHISPHARMA to CAPITOLIUM 15-01Dividend €50,000Cash from €259 to €367

Key points

from the 2025 annual accounts

Equity

€349,657 ▼ 9.3%
385,3662024+14,291Profit-50,000Dividend349,6572025

CAPITOLIUM paid out €50,000 in dividends. That is 350% of the 2025 profit.

Turnover

≈ €120,000 estimated

The accounts state no turnover.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

Nine of the last ten came late. The 2019 accounts came in latest, 91 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 14,780 companies had the same profile as CAPITOLIUM has now. Each dot stands for 37 companies, two years later.

96.2%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 14,780 companies, not a prediction for CAPITOLIUM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director,
Managing director,
Director, since 01-10-2014
Director, since 01-10-2014
  • 100%score equity €487,128 (2025) · annual accounts 2024 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0477642648
Company renamed from GHISPHARMA to CAPITOLIUM resigns as managing director · and act as permanent representatives · (director) and (director) reappointed · General meeting of 27-12-2024 · Gazette deed
3 directors appointed, 2 resignations and resign · (managing director), (managing director) and appointed · and act as permanent representatives · General meeting of 01-10-2014 · Gazette deed
(managing director) and (director) reappointed General meeting of 11-05-2013 · Gazette deed
All 39 events

Official details

Source: KBO
Status
Active since 23-05-2002Normal situation
Activity
Retail sale of pharmaceutical productsNACE 477301 activity on the establishment unitFrom the articles, 16 activities
Establishment unit
2.134.571.6071040 Etterbeek, since 30-05-2002
Financial year end
31 December
Peppol
Reachable since 19-12-2025
Company details

Annual accounts 2025

€923,258▼ 2.3%
Filing
Filed on 31-07-2026, on the last day of the filing period
Financials

Companies linked to CAPITOLIUM

Parent and group

Insights on CAPITOLIUM

CAPITOLIUM files the micro format. That format states no turnover. The gross margin fell from €87,938 in 2002 to €30,212 in 2025.

The balance sheet grew most from 2019 to 2021 through fixed assets.

holds all the shares. In January 2025, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CAPITOLIUM

What is the company number of CAPITOLIUM?
The company number of CAPITOLIUM is 0477.642.648. The VAT number is the same number with BE in front: BE 0477.642.648.
Where is CAPITOLIUM based?
The registered office is at Tongerenstraat 25, 1040 Etterbeek.Company details
What does CAPITOLIUM do?
According to the KBO register, the main activity of the establishment unit is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of CAPITOLIUM?
CAPITOLIUM is a public limited company (NV).
When was CAPITOLIUM founded?
CAPITOLIUM was founded on 23-05-2002.
Is CAPITOLIUM still active?
Yes, CAPITOLIUM is an active enterprise in the KBO register.
What is the turnover of CAPITOLIUM?
The turnover in financial year 2025 is about €120,000. This figure is estimated from the gross margin of €30,212 and 3,268 comparable companies of the same size. It probably lies between €72,000 and €210,000. It is a rough estimate.Financials
Is CAPITOLIUM profitable?
In financial year 2025, CAPITOLIUM made a profit of €14,291.
Where can I find the annual accounts of CAPITOLIUM?
CAPITOLIUM filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CAPITOLIUM due?
CAPITOLIUM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.